GIA
PAVM icon

Gladstone Institutional Advisory’s PAVmed PAVM Stock Holding History

Gladstone Institutional Advisory’s Portfolio PAVM Stock Details PAVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-29
Closed -$57K – 541
2021
Q1 		$57K Buy
+29
New +$43.6K 0.01% 410

Other funds holding PAVM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return

Gladstone Institutional Advisory's PAVM Position: Q2 2021 in Review

Gladstone Institutional Advisory sold out of PAVmed (PAVM) in Q2 2021, closing a stake of 29 shares — an estimated $57K sold.

Gladstone Institutional Advisory first reported a position in PAVM in Q1 2021 and held it in 1 quarter. The position peaked at $57K in Q1 2021. 97 funds tracked by Wall St. Rank hold PAVM as of Q2 2021.

  • Gladstone Institutional Advisory reported no remaining PAVmed position as of Q2 2021 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 29 PAVmed shares in Q2 2021, an estimated $57K.
  • Gladstone Institutional Advisory first reported a position in PAVmed in Q1 2021 and held it in 1 quarter.
  • Gladstone Institutional Advisory's PAVmed position peaked at $57K in Q1 2021.
  • 97 funds tracked by Wall St. Rank held PAVmed as of Q2 2021.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2021, filed 13 Aug 2021.